UPDATED Sept. 30, 2011
Patent Infringement
BSX will pay big to the DOJ, Covidien loses bid in torcar war against AMR, Mela Sciences shares surge on FDA approval | MassDevice.com +3
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
Covidien loses bid in trocar war with Applied Medical Resources
A federal judge in Texas “has a hard time” with arguments presented by Covidien plc (NYSE:COV) in its long-running patent spat with Applied Medical Resources over surgical trocars.
Judge nixes J&J’s bid to sidestep a $482 million Cordis verdict | Legal News
It’s been a tough stretch in the courtroom for Johnson & Johnson’s (NYSE:JNJ) Cordis Corp.
The health care giant’s stent-making unit lost its bid for a new trial in the $482 million patent infringement lawsuit it lost to stent pioneer Dr. Bruce Saffran Tuesday.
That loss followed the failure of its bid to overturn a pair of U.S. Patent Office rules.
Judge nixes J&J’s bid to sidestep a $482 million Cordis verdict
It’s been a tough stretch in the courtroom for Johnson & Johnson’s (NYSE:JNJ) Cordis Corp.
The health care giant’s stent-making unit lost its bid for a new trial in the $482 million patent infringement lawsuit it lost to stent pioneer Dr. Bruce Saffran Tuesday.
That loss followed the failure of its bid to overturn a pair of U.S. Patent Office rules.
Cordis loses case against U.S. Patent Office
Cordis Corp., the stent-making arm of Johnson & Johnson (NYSE:JNJ), lost its legal challenge to a pair of U.S. Patent & Trademark Office rules because it filed the lawsuit too late, according to a ruling by a federal judge in Virginia.
MDT wins $101 million against NuVasive, IOM’s 510(k) report panned by industry, BSX gets a pat on the back from judge in shareholder lawsuit | MassDevice.com +3
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Medtronic’s big win over NuVasive
FLASH: Jury splits verdict in Medtronic, NuVasive patent spat
Applied Medical Resources trocar patent war with Covidien set for another round
The latest in a series of lawsuits between Applied Medical Resources Corp. and Covidien plc (NYSE:COV) is slated to go before a jury later this month, after a federal judge in Texas denied AMR’s motion for summary judgment in the case.
Patent reform and med-tech: The America Invents Act promises to be a game-changer
This week President Barack Obama is expected to sign a patent reform bill marking the most dramatic changes to the patent system in decades, drawing adulation and ire from varying sectors of the innovation economy.
The American Invents Act, six years in the making, contains several sweeping changes, but the main bone of contention is a transformation of the U.S. patent system from a first-to-invent application process to a first-to-file process.